The DOI matches its Crossref record.
Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism
Open accessAbstract
Octreotide, a long-acting analog of somatostatin that inhibits insulin release, has the potential to control hypoglycemia in infants with congenital hyperinsulinism. To examine the efficacy and side effects of octreotide, we evaluated therapy between 1988 and 1993 in 16 infants who did not respond to diazoxide. In nine patients with onset of severe hypoglycemia in the first days of life, octreotide was helpful in stabilizing plasma glucose levels and allowed reductions in the rates of glucose infusion; however, glucose control was inadequate to avoid subtotal pancreatectomy. In two of these nine patients postoperatively and in seven other infants, a trial of long-term treatment with octreotide was undertaken. Four were treated successfully for up to 4.3 years. Octreotide therapy was not associated with thyroid deficiency and caused only transient malabsorption. All patients receiving long-term therapy had some decrease in linear growth and two had subnormal plasma concentrations of insulin-like growth factor I and insulin-like growth factor binding protein 3 compatible with suppression of growth hormone by octreotide. Resistance to octreotide therapy, even with increasing doses, occurred in all patients. These results suggest that octreotide may aid in the acute or long-term treatment of congenital hyperinsulinism in a limited number of selected cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Congenital hyperinsulinism: current trends in diagnosis and therapy
Arnoux, J.-B., Verkarre, V., Saint-Martin, C., Montravers, F., Brassier, A., Valayannopoulos, V., Brunelle, F., Fournet, J.-C., Robert, J.-J., Aigrain, Y., et al. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-63 · Cited by 361
Clinical Features of 52 Neonates with Hyperinsulinism
de Lonlay-Debeney, P., Poggi-Travert, F., Fournet, J.-C., Sempoux, C., Vici, C. D., Brunelle, F., Touati, G., Rahier, J., Junien, C., Nihoul-Fékété, C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401505 · Cited by 294
Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders
Stanley, C. A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3651 · Cited by 239
Leibowitz, G., Glaser, B., Higazi, A. A., Salameh, M., Cerasi, E., & Landau, H. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.2.7852494 · Cited by 156
Factitious hyperinsulinism leading to pancreatectomy: severe forms of Munchausen syndrome by proxy
Giurgea, I., Ulinski, T., Touati, G., Sempoux, C., Mochel, F., Brunelle, F., Saudubray, J.-M., Fekete, C., & de Lonlay, P. (2005) · Pediatrics · doi:10.1542/peds.2004-2331 · Cited by 76
Metadata
- Authors
- Thorton, P. S., & Alter, C. A.
- Venue
- The Journal of Pediatrics
- Publisher
- Elsevier BV
- Published
- 1993-10
- Volume
- 123
- Issue
- 4
- Pages
- 637-643
- ISSN
- 0022-3476 (ISSN-L)
- OpenAlex
- W2042683979
- Cited by
- 158
- References
- 0
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism. https://app.cochat.ai/papers/10.1016/s0022-3476(05)80969-2
- The paper
- Thorton, P. S., & Alter, C. A. (1993). Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism. The Journal of Pediatrics. https://doi.org/10.1016/s0022-3476(05)80969-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.